The Swiss drugmaker will pay $1.1 billion upfront and up to $400 million in milestones to gain a novel antibody-drug conjugate payload platform
Please enable cookies.
This website is using a security service to protect itself from online attacks. The action you just performed triggered the security solution. There are several actions that could trigger this block including submitting a certain word or phrase, a SQL command or malformed data.
You can email the site owner to let them know you were blocked. Please include what you were doing when this page came up and the Cloudflare Ray ID found at the bottom of this page.
Cloudflare Ray ID: a172d622296208d5 • Your IP: 45.147.101.248 • Performance & security by Cloudflare
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | 2 Firms Lead Merck's $11.3B Bio-Techne Life Sciences Deal | 0 | 7 | 25-06-2026 |
| 2 | Neurocrine’s $2.9B Soleno Buyout Brings What Could Become Its Next Blockbuster Drug | 5 | 7 | 07-04-2026 |
| 3 | Why Biogen Is Paying $5.6B to Buy Apellis Pharma | 0 | 5 | 03-04-2026 |
| 4 | ТМК рассчитывает закрыть сделку по продаже американской "дочки" в IV квартале 2019 года | 0 | 0 | 16-08-2019 |
| 5 | Петербургская компания вложила 400 млн рублей в испытания препарата для лечения COVID-19 | 0 | 0 | 08-06-2020 |
| 6 | Gilead’s Pipeline Strategy Takes Shape With $3B Acquisition of Cancer Biotech Tubulis | 0 | 5 | 08-04-2026 |
| 7 | АФК "Система" купила доли в двух фармпредприятиях | 0 | 0 | 08-08-2019 |
| 8 | В Свердловскую область завезли препарат для онкобольных "Оксалиплатин" | 0 | 5 | 26-06-2026 |
| 9 | "Ростех" инвестирует 8 млрд руб. в центр протонной терапии рака в Новосибирске | 0 | 0 | 17-09-2019 |
| 10 | Pandemic darlings Moderna, BioNTech are now on two different paths | 0 | 7 | 31-07-2025 |